Postby roadrunner » Wed Mar 18, 2020 10:46 pm
Not sure what the nature or potential effect of the auto-immune disorder is, but I would consider blood counts in any attempt to try to balance risk. Has the 5-FU suppressed immune function so far? If I recall right, it is generally regarded as significantly less immunosuppressive than FOLFOX. But also consider that there can be suppression for a while after chemo is discontinued (when the virus may be more widespread). Also, things like where you live may be relevant — in the US the rate of infection is much higher in some areas than others, though the data is admittedly still very spotty. It’s a tough call, I wish you the best.
7/19: RC: Staged IIIA, T2N1M0
approx 4.25 cm, low/mid rectum, mod. well diff.; lung micronodule
8/19-10/19 4 rds.FOLFOX neoadjuvant, 3 w/Oxiplatin (reduced 70-75%)
neoadjuvant chemorad 11/19
4 rounds FOLFOX July-August 2020
ncCR 10/20; biopsies neg
TAE 11/20, tumor cells removed
Chest CT 3/30/21 growth in 2 nodules (3 and 5mm)
VATS 12/8/21 sub-pleural met 7mm.
SBRT nodule 1/22
6/20/22 TAE rectal polyp benign)
NED from 3/22 - 3/23
4 cycles FOLFIRI
LUL VATS lobectomy for radio resistant met 7/7/23